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Objectives: We sought to prospectively compare the prognostic value of
cardiac iodine-123 (I-123) metaiodobenzylguanidine (MIBG) imaging with
peak oxygen comsumption (VO2) and plasma BNP level in patients with
advanced heart failure (AHF) waiting for heart transplant.
Bakground: In mild to moderate heart failure, cardiac fixation of MIBG
reflecting presynaptic uptake is reduced, exercise capacity is altered and
plasma BNP level is increased. In AHF prognostic value of these parameters
is still unknown.
Methods: Fifty one patients with advanced heart failure were studied with
planar MIBG imaging, cardiopulmonary exercise tests, hemodynamic and neu-
rohormonal parameters. Early (30 min) and late (4 h) MIBG acquisition, as
well as their ratio (washout rate, WOR) were determined. Prognostic value
was assessed by survival curves (Kaplan-Meier method) and uni- and multi-
variate Cox analyses.
Results: Early and late cardiac MIBG uptake were correlated with ejec-
tion fraction (r=0.33 and r=0.42). With a median follow up of 494 days,
NYHA (p=0.03), plasma BNP (p=0.002), peak VO2 (p=0.03) were predic-
tive of death or heart transplantation, but only plasma BNP emerged by mul-
tivariate analysis. WOR>36.63% (1st quartile) was predictive on kaplan-
Meier analysis.
Conclusions: In AHF patients, VO2 and BNP plasma level are stronger
prognosticator than MIBG imaging related parameters. MIBG should be
reserved to patients with mild to moderate heart failure while BNP remains the
most powerful prognostic index whatever the severity of heart failure.
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Background: Levosimendan is a new inodilatory agent with calcium sen-
sitizing activity. A major concern regarding the use of inotropic agent in heart
failure is their effect on the sympathetic tone. This effect could explain
increase in short term mortality with other inotropes. In this setting, the aim of
our study was to assess the effect of levosimendan on sympathetic tone mea-
sured directly by microneurography.
Methods: In a group of acute decompensated heart failure patients, we
assessed cardiac performance by digital plethysmography (Finometer©) mea-
surement. Sympathetic tone was assessed through recording of muscle sympa-
thetic nerve activity by microneurography. Recording were done blindy, for
each patient after dobutamine perfusion was stopped (baseline) and 48 hours
after levosimendan infusion. Clinical, biological and morphological data were
collected. We compared cardiac parameters and sympathetic nerve activity
before and after administration of levosimedan.
Results: 13 patients with refractory chronic heart failure were recruited
(aged 48±3.6 years). Systolic blood pressure and rate pressure product
(mmHg x Beat/min) decreased significantly after levosimendan infusion
(p<0.05). Cardiac output and stroke volume assessed by Finometer were
significantly increased after levosimendan infusion (p<0.05). A significant
decrease of muscle sympathetic nerve activity is observed after levosim-
endan infusion (p<0.01). Levosimendan cause a significant reduction of
plasma brain natriuretic preptide (BNP) after the initiation of the drug
(p<0.01).
Conclusion: Levosimendan induced improvement of cardiac performance
is associated with a decreased in MSNA. This study show for the first time
that levosimendan has no direct detrimental effect on the sympathetic nervous
system.
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Background: Plasma BNP is widely used in the management of patients
with systolic heart failure; however it has been less studied in patients with
hypertrophic cardiomyopathy. We hypothetized that increased plasma BNP
level could be associated with heart failure symptoms and increased left ven-
tricle filling pressure in patients with HCM.
Methods: We studied 62 consecutive patients with HCM admitted for
evaluation in our outpatient clinic. In all patients, clinical examination, com-
plete echocardiography and plasma BNP and creatinine measurements were
performed. 
Results: The mean BNP value was 297 ± 282 pg/mL. In univariate anal-
ysis, BNP showed a significant relationship to age (R_ = 0,1862; p = 5.10-
4), magnitude of dyspnea, expressed by New York Heart Association
(NYHA) functional class: I, 114 ± 114 pg/mL; II, 224 ± 168 pg/mL; III,
523 ± 280 pg/mL; IV, 816 ± 368 pg/mL (p < 10-4), atrial fibrillation (p <
0,009) and creatinine clearance (R_ = 0,2328; p < 10-4). BNP levels were
also correlated with lateral annular Ea velocity (R_ = 0,2148; p = 10-4),
increased LV filling pressure defined as E/A > 2 or E/Ea > 10 (R_ = 0,376;
p < 10-4), left atrial size (R_ = 0,1686; p = 9.10-4), systolic pulmonary
arterial pressure (R_ = 0,2299; p < 10-4). There was no relation between
BNP and LV outflow tract gradient at rest or maximal LV wall thickness.
Variables with significant multivariable relation with BNP were NYHA
functional class, mitral lateral Ea velocity, increased LV filling pressure,
and creatinine clearance.
Conclusion: BNP levels in patients with HCM are related to the presence
and magnitude of heart failure symptoms and LV filling pressure. Its prog-
nostic value should be evaluated in these patients. 
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Introduction: In healthy subject hyperoxia enhances metaboreflex sensi-
tivity during static exercise. However the influence of chronic heart failure on
metaboreflex sensibility remains a matter of controversies. Moreover the effect
of hyperoxia on this reflex in CHF patients is unknown. This is of importance
since these patients regularly receive chronic administration of nasal oxygen
during hospital admission.
Methods: The effects of breathing 21% (normoxia) and 100% oxygen
(hyperoxia) at rest and during isometric handgrip at 30% of maximal voluntary
contraction on MSNA, heart rate (HR), blood pressure (systolic, diastolic,
mean and pulse pressure) and O2 saturation (DaO2) were determined in 14
patients with heart failure. The isometric handgrips were followed by 3 min of
post-exercise circulation arrest (PE-CA) to allow metaboreflex activation in
the absence of other reflex mechanisms.
Results: In normoxia, hangrip and PE-CA induced an expected increase in
MSNA and hemodynamic parameters (BP, HR ; all p<0,05). Hyperoxia
enhanced resting diastolic, mean blood pressure and SaO2 (all p<0,05), but
without effects on MSNA responses. Hyperoxia did not modifiy expected
